What is the recommended fluid management for patients with dengue fever and plasma leakage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Dengue Fever with Plasma Leakage

Immediate Fluid Resuscitation for Dengue Shock Syndrome

For patients with dengue shock syndrome, administer an initial bolus of 20 mL/kg of isotonic crystalloid (Ringer's lactate or 0.9% normal saline) over 5-10 minutes, with immediate reassessment after each bolus and readiness to repeat up to 40-60 mL/kg in the first hour if shock persists. 1

Initial Crystalloid Resuscitation Protocol

  • Start with isotonic crystalloid solutions as first-line therapy - either Ringer's lactate or 0.9% normal saline are equally effective for initial resuscitation 1, 2

  • Administer the 20 mL/kg bolus as rapidly as possible over 5-10 minutes, then immediately reassess for signs of improvement 1, 3

  • If shock persists after the initial bolus, repeat crystalloid boluses up to a total of 40-60 mL/kg within the first hour before considering escalation to colloids 1, 2

  • Evidence demonstrates that aggressive crystalloid resuscitation achieves near 100% survival when properly administered in dengue shock syndrome 1

When to Escalate to Colloid Solutions

If shock persists despite 40-60 mL/kg of crystalloid in the first hour, switch to colloid solutions rather than continuing aggressive crystalloid administration. 1, 4

  • Moderate-quality evidence shows colloids achieve faster resolution of shock (RR 1.09,95% CI 1.00-1.19) compared to crystalloids alone 1

  • Colloids require significantly less total volume for resuscitation - mean 31.7 mL/kg versus 40.63 mL/kg for crystalloids 1

  • Dextran 70 is the preferred colloid as it provides the most rapid normalization of hematocrit and restoration of cardiac index without adverse effects 5

  • Alternative colloids include gelafundin or albumin if dextran is unavailable 1, 6

  • Both dextran and haes-steril (hydroxyethyl starch) are equally effective with no differences in renal function or hemostasis complications 6

Critical Monitoring Parameters During Resuscitation

Clinical Endpoints of Adequate Resuscitation

  • Target these specific clinical indicators rather than arbitrary fluid volumes: normal capillary refill time, absence of skin mottling, warm and dry extremities, well-felt peripheral pulses, return to baseline mental status, and adequate urine output 1, 2

  • Monitor hematocrit closely - rising hematocrit indicates ongoing plasma leakage requiring continued resuscitation, while falling hematocrit suggests successful plasma expansion 1, 2

  • Track improvement in tachycardia and tachypnea as signs of adequate resuscitation 1

  • Daily complete blood count monitoring is essential to track platelet counts and hematocrit levels 1

Signs Requiring Immediate Change in Strategy

Stop fluid resuscitation immediately if any of these develop: 1, 2

  • Hepatomegaly (indicates fluid overload)
  • Pulmonary rales on lung examination
  • Respiratory distress
  • Pleural effusion or ascites requiring drainage (avoid drainage as it can lead to severe hemorrhage and sudden circulatory collapse) 3

Management of Refractory Shock

When shock persists despite adequate fluid resuscitation (40-60 mL/kg crystalloid plus colloids), switch from aggressive fluid administration to inotropic support rather than continuing fluid boluses. 1, 2

Vasopressor Selection Based on Hemodynamic State

  • For cold shock with hypotension: titrate epinephrine as first-line vasopressor 1, 2

  • For warm shock with hypotension: titrate norepinephrine as first-line vasopressor 1, 2, 4

  • Target mean arterial pressure appropriate for age and maintain ScvO2 >70% 1

  • Begin peripheral inotropic support immediately if central venous access is not readily available, as delays in vasopressor therapy significantly increase mortality 1

Fluid Management for Non-Shock Dengue with Plasma Leakage

Oral Rehydration Strategy

  • Encourage approximately 2,500-3,000 mL daily oral intake, which evidence shows reduces hospitalization rates 1, 2

  • Use any locally available fluids including water, oral rehydration solutions, cereal-based gruels, soup, and rice water 1, 2

  • Avoid soft drinks due to high osmolality 1, 2

  • Practical approach: encourage 5 or more glasses of fluid throughout the day 1

Warning Signs Requiring IV Fluid Therapy

Monitor for these indicators that plasma leakage is progressing and IV fluids may be needed: 1, 2

  • High hematocrit with rapidly falling platelet count
  • Severe abdominal pain
  • Persistent vomiting
  • Lethargy or restlessness
  • Mucosal bleeding
  • Tachycardia, poor capillary refill, cold extremities, narrow pulse pressure

Critical Pitfalls to Avoid

Do NOT Give Routine Bolus IV Fluids to Patients Without Shock

The most important pitfall is administering bolus intravenous fluids to patients with "severe febrile illness" who are not in shock - this increases fluid overload and respiratory complications without improving outcomes 1, 2

  • High-quality evidence shows no benefit from routine bolus fluids in patients without shock 1

Do NOT Use Restrictive Fluid Strategies in Established Shock

  • Moderate-quality evidence shows no survival benefit from restrictive fluid strategies in dengue shock syndrome 1

  • Restrictive fluids in severe malaria showed harm with increased need for rescue fluid (17.6% versus 0.0%; P<0.005), suggesting similar risks in dengue shock 1

  • Delaying fluid resuscitation in established dengue shock syndrome significantly increases mortality 1

Do NOT Continue Aggressive Fluids Once Overload Develops

  • After initial shock reversal, fluid removal may be necessary - evidence shows that aggressive shock management followed by judicious fluid removal decreased pediatric ICU mortality from 16.6% to 6.3% 1

  • Consider continuous renal replacement therapy (CRRT) if fluid overload >10% develops 1

Do NOT Fail to Recognize the Critical Phase

  • The critical phase typically occurs on days 3-7 of illness when plasma leakage can rapidly progress to shock 1, 2

  • A rise in hematocrit of 20% along with continuing drop in platelet count is an important indicator for onset of shock 3

Supportive Care Considerations

  • Use acetaminophen (paracetamol) only for pain and fever management 1, 2

  • Avoid aspirin and NSAIDs due to increased bleeding risk 1

  • Blood transfusion may be necessary for significant bleeding - target hemoglobin >10 g/dL if ScvO2 <70% 1, 2

  • Resume age-appropriate diet as soon as appetite returns 1

References

Guideline

Dengue Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dengue Fluid Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of dengue fever in ICU.

Indian journal of pediatrics, 2001

Research

FLUID AND HEMODYNAMIC MANAGEMENT IN SEVERE DENGUE.

The Southeast Asian journal of tropical medicine and public health, 2015

Research

Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999

Research

Choice of colloidal solutions in dengue hemorrhagic fever patients.

Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2008

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.